Dividend Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 218.82 USD | -0.95% |
|
+5.04% | +9.70% |
EPS & Dividend: Charles River Laboratories International, Inc.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 7.2 | 7.6 | 9.48 | 9.22 | 0.2 | 4.193 | 7.215 | 9.109 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Reference price 2 | 247.17 | 371.96 | 215.04 | 238.78 | 186.16 | 218.82 | 218.82 | 218.82 |
| Nbr of stocks (in thousands) | 49,743 | 50,464 | 50,879 | 51,297 | 51,136 | 49,215 | 49,215 | - |
| Announcement Date | 17/02/21 | 16/02/22 | 22/02/23 | 14/02/24 | 19/02/25 | - | - | - |
1USD in Million2USD
Estimates
Upcoming events: Charles River Laboratories International, Inc.
More events
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | 52.18x | 3.05x | 3.17x | ||
| 0.87% | 0.99% | 39.34x | 4.05x | 5.7x | ||
| -.--% | -.--% | 33.91x | 6.46x | 3.36x | ||
| -.--% | -.--% | 102.18x | 9.24x | 6.54x | ||
| 0.34% | 0.35% | 56.5x | 2.7x | 11.6x | ||
| -.--% | -.--% | -20.97x | 14.27x | 6085.09x | ||
| - | - | - | - | - | ||
| -.--% | -.--% | 40.48x | 40.42x | 6.56x | ||
| 0.87% | 0.95% | 27.95x | 2.41x | 2.22x | ||
| -.--% | -.--% | 26.74x | 1.47x | 2.08x | ||
| Average | 0.23% | 0.25% | 39.81x | 9.34x | 680.70x | |
| Weighted average by Cap. | 0.28% | 0.31% | 43.94x | 8.34x | 582.78x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















